Fayez Sarofim & Co’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297M Sell
3,278,314
-1,003,821
-23% -$91.6M 0.7% 37
2026
Q1
$440M Sell
4,282,135
-198,385
-4% -$22.4M 1.12% 26
2025
Q4
$561M Sell
4,480,520
-35,444
-0.8% -$4.52M 1.35% 24
2025
Q3
$609M Sell
4,515,964
-6,333
-0.1% -$831K 1.41% 21
2025
Q2
$619M Sell
4,522,297
-99,447
-2% -$13.1M 1.49% 21
2025
Q1
$618M Sell
4,621,744
-54,054
-1% -$6.88M 1.54% 19
2024
Q4
$533M Buy
4,675,798
+486,028
+12% +$56.2M 1.3% 26
2024
Q3
$478M Buy
4,189,770
+59,051
+1% +$6.48M 1.21% 27
2024
Q2
$429M Buy
4,130,719
+101,432
+3% +$10.8M 1.16% 27
2024
Q1
$458M Sell
4,029,287
-2,921
-0.1% -$335K 1.36% 26
2023
Q4
$451M Sell
4,032,208
-269,128
-6% -$26.9M 1.38% 24
2023
Q3
$417M Buy
4,301,336
+370,199
+9% +$38.9M 1.41% 23
2023
Q2
$429M Sell
3,931,137
-148,160
-4% -$15.8M 1.5% 24
2023
Q1
$413M Sell
4,079,297
-189,866
-4% -$20M 1.45% 24
2022
Q4
$469M Sell
4,269,163
-272,636
-6% -$28.2M 1.73% 20
2022
Q3
$439M Sell
4,541,799
-16,520
-0.4% -$1.76M 1.74% 20
2022
Q2
$495M Sell
4,558,319
-20,337
-0.4% -$2.31M 1.81% 20
2022
Q1
$542M Sell
4,578,656
-157,866
-3% -$19.6M 1.71% 18
2021
Q4
$667M Sell
4,736,522
-26,942
-0.6% -$3.45M 2% 11
2021
Q3
$563M Buy
4,763,464
+214,418
+5% +$26.3M 1.86% 14
2021
Q2
$527M Buy
4,549,046
+14,591
+0.3% +$1.7M 1.77% 15
2021
Q1
$543M Buy
4,534,455
+7,184
+0.2% +$851K 2% 12
2020
Q4
$496M Buy
4,527,271
+35,834
+0.8% +$3.9M 1.9% 14
2020
Q3
$489M Buy
4,491,437
+144,195
+3% +$14.6M 2.09% 13
2020
Q2
$397M Buy
4,347,242
+665,577
+18% +$60.2M 1.83% 18
2020
Q1
$291M Buy
3,681,665
+8,644
+0.2% +$721K 1.79% 18
2019
Q4
$319M Sell
3,673,021
-89,957
-2% -$7.53M 1.54% 25
2019
Q3
$315M Buy
3,762,978
+43,772
+1% +$3.72M 1.62% 21
2019
Q2
$313M Sell
3,719,206
-86,744
-2% -$6.83M 1.62% 23
2019
Q1
$304M Buy
3,805,950
+10,978
+0.3% +$817K 1.61% 20
2018
Q4
$274M Sell
3,794,972
-72,834
-2% -$5.12M 1.65% 19
2018
Q3
$284M Sell
3,867,806
-54,185
-1% -$3.56M 1.48% 21
2018
Q2
$239M Sell
3,921,991
-86,997
-2% -$5.27M 1.29% 27
2018
Q1
$240M Sell
4,008,988
-47,632
-1% -$2.87M 1.3% 27
2017
Q4
$232M Sell
4,056,620
-258,895
-6% -$14.3M 1.2% 29
2017
Q3
$230M Sell
4,315,515
-63,522
-1% -$3.19M 1.21% 28
2017
Q2
$213M Sell
4,379,037
-131,297
-3% -$5.94M 1.14% 29
2017
Q1
$200M Sell
4,510,334
-366,812
-8% -$15.9M 1.09% 28
2016
Q4
$187M Sell
4,877,146
-253,394
-5% -$10M 1.03% 30
2016
Q3
$217M Sell
5,130,540
-135,180
-3% -$5.79M 1.18% 25
2016
Q2
$207M Sell
5,265,720
-16,890
-0.3% -$672K 1.13% 26
2016
Q1
$221M Sell
5,282,610
-65,801
-1% -$2.61M 1.27% 26
2015
Q4
$239M Sell
5,348,411
-154,303
-3% -$6.81M 1.38% 21
2015
Q3
$222M Sell
5,502,714
-328,846
-6% -$15.5M 1.28% 22
2015
Q2
$286M Sell
5,831,560
-259,152
-4% -$12.4M 1.46% 18
2015
Q1
$282M Sell
6,090,712
-44,514
-0.7% -$2.04M 1.38% 19
2014
Q4
$276M Sell
6,135,226
-132,214
-2% -$5.76M 1.31% 22
2014
Q3
$260M Sell
6,267,440
-109,477
-2% -$4.63M 1.22% 25
2014
Q2
$261M Buy
6,376,917
+15,099
+0.2% +$593K 1.19% 28
2014
Q1
$245M Sell
6,361,818
-80,153
-1% -$3.09M 1.17% 30
2013
Q4
$247M Buy
+6,441,971
New +$237M 1.15% 32
2013
Q2
$221M Buy
+6,346,309
New +$233M 1.11% 30

Other funds holding ABT

Fayez Sarofim & Co's ABT Position: Q2 2026 in Review

Fayez Sarofim & Co reduced its Abbott (ABT) stake by 23% in Q2 2026, selling an estimated $91.6M and leaving 3,278,314 shares worth $297M. The position accounts for 0.7% of the portfolio, ranked #37.

Fayez Sarofim & Co first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $667M in Q4 2021. 2,950 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Fayez Sarofim & Co held 3,278,314 shares of Abbott worth $297M as of Q2 2026.
  • Fayez Sarofim & Co sold 1,003,821 Abbott shares in Q2 2026, an estimated $91.6M.
  • Abbott made up 0.7% of Fayez Sarofim & Co's portfolio in Q2 2026, its #37 holding.
  • Fayez Sarofim & Co first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
  • Fayez Sarofim & Co's Abbott position peaked at $667M in Q4 2021.
  • 2,950 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.